Ilioinguinal Nerve Block in Transcatheter Aortic Valve Implantation

• Status: Recruiting
• Trial end date: 2022-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the effect of iliohypogastric and ilioinguinal nerve block on the hemodynamic stability ,narcotic consumption and the rate of conversion to general anesthesia in patients undergoing transfemoral transcatheter aortic valve implantation (TF-TAVI).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Bupivacaine; Lidocaine

Criteria

Inclusion Criteria:

• • Patients undergoing TF-TAVI.

• Both sexes.

• Age 18 and above

Exclusion Criteria:

• • Inability to tolerate supine position as in patients with musculoskeletal disease or back pain, OR in patients with congestive heart failure or with obstructive sleep apnea.

• Patients with severe pulmonary hypertension (PAP>60 mmhg)

• Barrier to communications as language barrier or dementia.

• Patients' preference of general anesthesia.

• Surgical consideration as transapical, subclavian approach, extensive TEE requirements.

• Patients with history of allergy to any drugs used.

• Patients with psychiatric disease.

• Patients with neurocognitive or neurodegenerative disease.

• Secondary exclusion criteria include abortion of the procedure, perioperative emergency conversion to general anesthesia and the need to cardiopulmonary resuscitation so the primary endpoint couldn't be detected in these conditions.